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The hypoxia-inducible factor-i DNA recognition site is cAMP-respon-
sive. The hypoxia-inducible factor-i (HIF-1) was first described as a DNA
binding activity that specifically recognizes an 8 bp hypoxia response
element (HRE) known to be essential for oxygen-regulated erythropoietin
gene expression. In clectrophoretic mobility shift assays (EMSA5) HIF-1
DNA binding activity is only detectable in nuclear extracts of cells
cultivated in a low oxygen atmosphere. In addition to HIF-1, a constitutive
DNA binding activity also specifically binds the HIF-1 probe. Based on
EMSAs using competitor oligonucleotides, specific antibodies and recom-
binant proteins, we previously reported that the constitutive HRE binding
factor is composed of ATF-i and CREB-1. Here we show that this site is
functionally responsive to the cAMP agonist 8Br-cAMP in a dose-
dependent manner under hypoxic but not under normoxic conditions.
These results were confirmed by using the protein kinase A (P1(A)
activator Sp-cAMPS and the PKA inhibitor Rp-cAMPS: while Sp-cAMPS
was synergistic with hypoxia on the HIF-1 DNA recognition site, the
Rp-cAMPS isomer showed no effect. Our findings suggest that the
PKA-signaling pathway is enhancing oxygen-dependent gene expression
via the HRE.
Oxygen-regulated expression of the erythropoietin (Epo) gene
in fetal liver and adult kidney is mediated by a hypoxia response
element (HRE) located in the 3' flanking region of the Epo gene
[1]. Using site-directed mutagenesis, an 8 bp motif has been
defined that is crucial for effector function of the HRE. Electro-
phoretic mobility shift assays (EMSA5) using a labeled HRE
probe detected a hypoxia-inducible factor (HIF-1) whose DNA
binding activity is strongly induced in extracts from cells exposed
to reduced oxygen concentrations [1]. Recent biochemical purifi-
cation and cloning revealed that HIF-1 is composed of two
subunits, a and /3, both belonging to the basic-helix-loop-helix-
PAS family of transcription factors [2, 31. While HIF-1/3 is
identical to the aryl hydrocarbon receptor nuclear translocator
(ARNT), human and murine HIF-la represent novel members of
this family [3, 4]. Besides this hypoxia-inducible factor, a specific
constitutive HRE binding activity is also present in these EMSAs
[1—3]. We previously reported that: (i) a cAMP-responsive ele-
ment (CRE)-containing oligonucleotide efficiently competed for
binding of the HIF-1 probe to this constitutive factor; (ii) mono-
clonal antibodies raised against the CRE binding factors ATF-1
and CREB-1 supershifted the constitutive factor; and (iii) recom-
binant ATF-1 and CREB-1 proteins bound HIFI probes either as
homodimers or as heterodimers [5]. Since these transcription
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factors are known to mediate the effects of the cAMP signaling
cascade [6—81, we investigated whether the HRE site might confer
a cAMP-dependent regulation of gene expression.
Methods
Cell culture, transient transfection and reporter gene assays
were performed as described in detail previously [5]. Briefly,
HeLa cells were co-transfected with each 25 jig of a luciferase
reporter plasmid and a /3-galactosidase expression vector
(pCMVpgal), which allows a correction for differences in trans-
fection efficiency and extract preparation. Ten minutes after
electroporation, the cells were split, incubated for 32 to 37 hours
at normoxic (20% 02) or hypoxic (1% 02) conditions, and lysed
for determination of reporter activity. The pGLEPOHRE.3 vec-
tor contained three copies of the EPO HRE downstream of the
luciferase gene which was driven by a heterologous SV4O pro-
moter [5]. As controls, the parental vector pGL3Promoter (Pro-
mega) and pGLEPOHREmt.3, which contained three mutated
copies of the EPO HRE [5], were included. The cAMP derivatives
used included 8-bromoadenosine-3',5'-cyclic monophosphate
(8Br-cAMP) and the isomers Sp-adenosine-3',5'-cyclic mono-
phosphothioate (Sp-cAMPS) and Rp-adenosine-3',5'-cyclic mon-
ophosphothioate (Rp-cAMPS).
Results
The cAMP agonist 8Br-cAMP enhances HRE function
To functionally assess the cAMP responsiveness of the EPO
HRE, a luciferase reporter gene containing three copies of a
HIF-1 DNA binding oligonucleotide (pGLEPOHRE.3) was tran-
siently transfected into HeLa cells. Subsequently, the cells were
treated with different concentrations of the cAMP agonist 8Br-
cAMP and cultured at normoxic or hypoxic conditions. As shown
in Figure 1, hypoxic reporter gene expression was enhanced by
8Br-cAMP in a dose-dependent manner, reaching the highest
value at 1 mM. In contrast, normoxic Iucifcrase expression re-
mained almost unaffected within this concentration range, indi-
cating that 8Br-cAMP effects are mediated by the HRE. To
directly demonstrate that the HRE is involved in this effect, HeLa
cells were also transfected with either the empty vector
(pGL3Promoter) alone, or with a reporter plasmid containing
three mutant EPO HRE sites (pGLEPOHREmt.3) [5]. As shown
in Figure 2, after transfection with pGLEPOHRE.3 hypoxia
alone increased luciferase expression by 6.3-fold (P < 0.01, N =
3, i-test). Luciferase expression in cells transfected with
pGLEPOHREmt.3 was not significantly different from the empty
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control vector, confirming that hypoxic induction is dependent on
the presence of HREs (Fig. 2). A weak hypoxic induction,
however, was already observed with the pGL3Promoter plasmid,
indicating that the SV4O promoter is slightly induced by hypoxia in
this cell line. However, one copy of the HRE oligonucleotide was
not sufficient to significantly enhance hypoxic reporter gene
expression [5]. After treatment with the cAMP agonist 8Br-cAMP
(1 mM), hypoxic luciferase expression was enhanced by 64%(P <0.005, N = 3, t-test), whereas pGL3Promoter- and
pGLEPOHREmt.3-transfected cells did not significantly induce
luciferase expression. Therefore, our results indicate that the
HRE is not only hypoxia-responsive but also cAMP-responsive.
A cAMP antagonist does not affect hypoxic reporter gene
expression
To examine whether cAMP potentiates hypoxic inducibility as a
result of an independent signaling pathway or as part of the
hypoxia signaling cascade itself, we repeated the experiments
mentioned above using the two isomers Sp-cAMPS (a cAMP
agonist) and Rp-cAMPS (a cAMP antagonist). If cAMP were
involved in the oxygen signal transduction pathway, a cAMP antag-
onist would decrease hypoxic inducibility of pGLEPOHRE.3. In
contrast, if cAMP were part of a parallel pathway leading to
enhanced expression after exposure to hypoxia, a cAMP antago-
nist would have no effect on reporter gene expression. As shown
in Figure 3, after incubation of transiently transfected HeLa cells
with 100 J.M of the corresponding cAMP isomers for 32 to 37
hours, the cAMP agonist Sp-cAMPS, similar to 8Br-cAMP,
enhanced hypoxic reporter gene induction by 50% (P < 0.05, N =
3, f-test), whereas the cAMP antagonist Rp-cAMPS had no
significant effect on hypoxic induction. As for 8Br-cAMP, Sp-
cAMPS neither had an effect under normoxic conditions, nor
were the HRE-deficient control plasmids responsive to this agent.
Conclusions
The results presented here confirm our previous observation
suggesting that the HRE is cAMP-responsive under hypoxic, but
not under normoxic conditions [51. Our observation that the
cAMP antagonist Rp-cAMPS does not influence hypoxic induc-
ibility (Fig. 3) indicates that cAMP is not a crucial element of the
hypoxia-activated signal transduction pathway per Se. However,
hypoxic induction of gene expression might act in concert with
other signaling pathways thereby enhancing the response to low
oxygen concentrations. The cAMP signaling cascade was also
found to be implicated in hypoxic EPO [9, 10] and lactate
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Fig. 2. 8Br-cAMP ejfrcts are dependent on functional HREs. Transiently transfected HcLa cells were treated with 1 mM 8Br-cAMP and cultured at 20%
or 1% °2 Copy number and orientation of the HREs derived from the EPO gene are indicated. Reporter gene expression is shown as percentage of
the respective untreated normoxic controls (means SD of 3 independent experiments). Normalization to the co-transfected /3-galactosidase was
inpracticable since the pCMV/3gal vector itself was activated by 1 mro (but not by 0.1 mM) 8Br-cAMP (1K., unpublished observations). Symbols are:
(L) 20% 02; () 20% 02 + 8Br-cAMP; (•) 1% °2; ([J) 1% °2 + SBr-cAMP.
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Fig. 1. Dose-dependent enhancement of hypoxic luciferase induction by
8Br-cAMP. A luciferase reporter construct (pGLEPOHRE.3) containing 3
HREs derived from the EPO gene 3' flanking region was transiently
transfected into HeLa cells which were split and exposed to either
normoxic or hypoxic conditions. Cells were treated with increasing
amounts of 8Br-cAMP as indicated. Symbols are: () 20% 02; (U) 1% °2
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Fig. 3. Hypoxic induction of reporter gene expression is independent of treatment with a cAMP antagonist. HeLa cells were transfected and cultured as
mentioned in Figure 2. Each 100 xM of a cAMP agonist (Sp-cAMPS) or the isomeric antagonist (Rp-cAMPS) were added to the cells. Copy number
and orientation of the HREs derived from the EPO gene are indicated. Reporter gene expression is normalized to the J3-galactosidase activity derived
from the co-transfected -galactosidase expression vector since at the used concentrations of cAMP analogues, no regulation of pCMVIIgal could be
observed. Results are shown as percentage of the respective untreated normoxic controls (means SD of 3 independent experiments). Symbols are: (LI)
20% °2; () 20% °2 + Sp-cAMPS; () 20% 07 + Rp-cAMPS; (U) 1% 02; ([1) 1% 02 + Sp-cAMPS; () 1% 02 + Rp-cAMPS.
dehydrogenase (LDH) induction [ii]. Recently, Firth, Ebert and
Ratcliffe reported the presence of a CRE separated by only 14 bp
from a HRE in the LDH promoter [121. The adenylate cyclase
activator forskolin enhanced hypoxic induction of gene expression
mediated by the HRE but reduced normoxic expression. Mutation
of the CRE site abolished forskolin-dependent synergy with
hypoxia, suggesting that the target sites of hypoxia and cAMP
signal transduction pathways reside in close vicinity on the LDH
promoter [12]. In contrast, our data provide evidence that, at least
in the EPO 3' enhancer, the cAMP effects might also be mediated
by the HRE itself.
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